This could be another tool that we'll have in our toolbox. - Eduardo Grunvald, MD, FACP, obesity medicine physician at #UCSDHealth
Garg R, Chen W, Pendergrass M
With the cost of GLP-1 medicines exceeding $1,000 per month, this combination of high drug costs and a large patient population has profound affordability implications for both plan sponsors and their members
As cardiologists, we believe SOUL trial benefits are very likely to apply to Indian patients, especially since Indians often develop diabetes, obesity, and heart disease at younger ages and lower BMI levels.Studies and the STEP-HFpEF trials suggest symptom and functional improvement with semaglutide in obesity-related heart failure
Acetic acid solution (0.6%): IGF-1 LR3 remains more stable in dilute acetic acid, maintaining potency for weeks to months when refrigerated